Timothy P Walbert has an estimated net worth of $321 Million. This is based on reported shares across multiple companies, which include Horizon Therapeutics Public Ltd Co, Aurinia Pharmaceuticals Inc., Sucampo Pharmaceuticals, Inc., XOMA Corp, Zyla Life Sciences, Mirum Pharmaceuticals, Inc., EXICURE, INC., Assertio Holdings, Inc., Century Therapeutics, Inc., Raptor Pharmaceutical Corp, NEOPHARM INC, IDM PHARMA, INC., Sagimet Biosciences Inc., BIOMARIN PHARMACEUTICAL INC, and Odyssey Therapeutics, Inc..

2014 was Timothy P Walbert's most active year for acquiring shares with 25 total transactions. Timothy P Walbert's most active month to acquire stocks was the month of December. 2022 was Timothy P Walbert's most active year for disposing of shares, totalling 64 transactions. Timothy P Walbert's most active month to dispose stocks was the month of December. 2019 saw Timothy P Walbert paying a total of $1,814,878.82 for 1,023,106 shares, this is the most they've acquired in one year. In 2023 Timothy P Walbert cashed out on 4,367,149 shares for a total of $118,220,729.64, their largest year based on trade value.